title: Can the skin smear examination in NLEP be reconsidered?
abstract: Slit and skin smear examination is an important laboratory test which was made optional in the NLEP. In a laboratory managed by LEPRA Society, this test was provided to voluntary reporting cases and those referred by the general health service institutions of the area. Total cases tested were 1180, out of which 152 (12.9%) were positive. Of the 152 smear reports, 121 were from Koraput district and constitute the sample for this study. Regarding the spread of site wise highest BI, 56% cases had BI of 3.1+ to 6+. Of the 121 cases, 112 (92.6%) cases completed 12 doses of MDT. Seventy patients, from whom detailed information was collected by personal contact, responded well to MDT resulting in regression of lesions. Out of them, 46 cases had repeat smear showing negative smear in 39% and decline of 81 in the rest of cases. There are 16 contact cases with 2 family clusters. A rough block-wise mapping showed 4 strata with a dense clustering in the urban area where the laboratory facility is available. The probable reasons for uneven distribution of cases and causes for late diagnosis were discussed. The study reflects the leprosy problem in urban pockets which high infection pool. Together these two factors remain unexposed due to winding up of smear labs and pose a potential threat to elimination. The paper also emphasized on the reasons for past failure of the test along with suggestions to revive this facility with minor modifications.
authors.affiliation: LEPRA Society, Regional Office, Bhubaneswar-751015, Orissa, India. porichha@leprahealthinaction.in
authors.forename: D
authors.initials: D
authors.lastname: Porichha
authors.forename: S
authors.initials: S
authors.lastname: Nayak
authors.forename: L B
authors.initials: LB
authors.lastname: Sahoo
authors.forename: N N
authors.initials: NN
authors.lastname: Sahoo
authors.forename: B N
authors.initials: BN
authors.lastname: Jinde
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D007918:Leprosy / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009313:National Health Programs; D012867:Skin / Q000473:pathology*